{
    "organizations": [],
    "uuid": "bd1f6c131a9dca84346f1996cee6795c1529a2be",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-abeona-therapeutics-receives-orpha/brief-abeona-therapeutics-receives-orphan-drug-designation-in-the-european-union-for-abo-202-gene-therapy-program-in-batten-disease-idUSFWN1RX0RS",
    "ord_in_thread": 0,
    "title": "BRIEF-Abeona Therapeutics Receives Orphan Drug Designation In The European Union For ABO-202 Gene Therapy Program In Batten Disease",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 20 (Reuters) - Abeona Therapeutics Inc:\n* ABEONA THERAPEUTICS RECEIVES ORPHAN DRUG DESIGNATION IN THE EUROPEAN UNION FOR ABO-202 GENE THERAPY PROGRAM IN BATTEN DISEASE Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-20T20:48:00.000+03:00",
    "crawled": "2018-04-21T17:57:49.002+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "abeona",
        "therapeutic",
        "inc",
        "abeona",
        "therapeutic",
        "receives",
        "orphan",
        "drug",
        "designation",
        "european",
        "union",
        "gene",
        "therapy",
        "program",
        "batten",
        "disease",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}